Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Childhood Oligoastrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Early research (Phase 1)Ended earlyNCT02255461
What this trial is testing

Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Who this might be right for
Childhood Choroid Plexus TumorChildhood EpendymoblastomaChildhood Grade III Meningioma+16 more
Pediatric Brain Tumor Consortium 35
Testing effectiveness (Phase 2)Study completedNCT00003372
What this trial is testing

Topotecan in Treating Patients With Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
NCIC Clinical Trials Group 17
Early research (Phase 1)Active Not RecruitingNCT07031765
What this trial is testing

Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma

Who this might be right for
Recurrent High-grade GliomaGrade III AstrocytomaOligodendroglioma+3 more
University of Florida 12
Testing effectiveness (Phase 2)Study completedNCT00679354
What this trial is testing

Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy

Who this might be right for
Childhood High-grade Cerebellar AstrocytomaChildhood High-grade Cerebral AstrocytomaRecurrent Childhood Anaplastic Astrocytoma+7 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT03043391
What this trial is testing

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children

Who this might be right for
Malignant GliomaAnaplastic AstrocytomaAnaplastic Oligoastrocytoma+8 more
Istari Oncology, Inc. 8
Not applicableWithdrawnNCT01711580
What this trial is testing

Re-irradiation of High Grade Gliomas: a Quality of Life Study

Who this might be right for
Anaplastic AstrocytomaGlioblastoma MultiformeAnaplastic Oligoastrocytoma
Maastricht Radiation Oncology
Very early researchStudy completedNCT00874861
What this trial is testing

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Who this might be right for
AstrocytomaOligoastrocytomaOligodendroglioma
Ian F. Pollack, M.D. 10
Testing effectiveness (Phase 2)Ended earlyNCT01110876
What this trial is testing

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma Multiforme
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00024570
What this trial is testing

Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
INSYS Therapeutics Inc 60
Testing effectiveness (Phase 2)Study completedNCT00995007
What this trial is testing

Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 112
Early research (Phase 1)Study completedNCT01156584
What this trial is testing

A Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma

Who this might be right for
GlioblastomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Tocagen Inc. 54
Testing effectiveness (Phase 2)WithdrawnNCT01740570
What this trial is testing

Phase I/II Cabazitaxel for Recurrent Malignant Glioma

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center